Metastatic Lung Cancer Presenting as an Acute Abdomen
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Introduction
Lung cancer is one of the leading causes of
cancer-related deaths in the world. A large
proportion of patients present with metastatic
disease and the predominant sites of spread
include brain, liver, adrenal glands, and bone.
Gastrointestinal (GI) metastasis from primary
lung carcinoma is rare; the small bowel is most
involved. Furthermore, GI perforation as a result
of metastatic lung cancer is extremely rare.
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Figure 1. Free intraperitoneal air under the R hemidiaphragm,
and L Perihilar lung mass (yellow arrow).
Figure 2. Focus of metastatic poorly differentiated carcinoma
(blue arrows) at the site of perforation (yellow arrow). 20X HE
stain.
Figure 3. High power view of metastatic poorly differentiated
carcinoma.
Figure 4. Immunohistochemical stain: The tumor cells show
positive cytoplasmic staining with Cytokeratin-7 (CK-7).
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Case Description
A 58-year-old male patient with advanced nonsmall cell lung carcinoma (NSCLC) presented
with sudden onset of diffuse abdominal pain,
nausea and vomiting. The patient had been
receiving
pembrolizumab
as
palliative
immunotherapy for biopsy-proven metastatic
lung cancer to the right iliac bone.
On examination, he had involuntary guarding in
the abdomen with rebound tenderness.
Abdominal x-ray revealed a large amount of
free intraperitoneal air.
He underwent emergent exploratory laparotomy
which revealed a 2 cm x 2.5 cm perforation at
the proximal jejunum with an adjacent
mesenteric lymph node enlargement. A liter of
intestinal contents was suctioned out and the
perforated segment was resected with an
adequate surgical margin. An end-to-end jejunal
anastomosis made to restore intestinal
continuity.
Histopathology of the jejunal specimen
demonstrated metastatic poorly differentiated
NSCLC which was identical to the findings
from the previous fine needle aspirate of the
right ilium soft tissue mass.
The patient was transferred to the intensive care
unit following surgery. His hospital course was
complicated by aspiration of GI contents during
intubation prior to surgery. His condition
improved gradually, and he was eventually
discharged in stable condition.

Discussion
Small bowel is a rare metastatic site for lung
cancer. A solitary small bowel metastasis is very
rare due to NSCLC. As seen in our case, the
jejunum is the most common gastrointestinal
site in most studies. [1-3]. In some series,
patients with bowel perforation as a result of
metastatic NSCLC had a mean survival of 66
days [4]. Our patient was able to return to work
six months after he underwent bowel resection
for an acute abdomen due to metastatic
perforation.
Conclusion
Acute abdomen due to metastatic lung cancer is
rare and contributes to a poor prognosis. Small
bowel metastases should be considered in a
lung cancer patient presenting with an acute
abdomen.
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